The DOI matches its Crossref record; 163 of the 163 references it cites were found in a registry or an index.
The Interaction Between NF-κB and Estrogen in Alzheimer’s Disease
Abstract
Post-menopausal women are at a higher risk of developing Alzheimer's disease (AD) than males. The higher rates of AD in women are associated with the sharp decline in the estrogen levels after menopause. Estrogen has been shown to downregulate inflammatory cytokines in the central nervous system (CNS), which has a neuroprotective role against neurodegenerative diseases including AD. Sustained neuroinflammation is associated with neurodegeneration and contributes to AD. Nuclear factor kappa-B (NF-κB) is a transcription factor involved with the modulation of inflammation and interacts with estrogen to influence the progression of AD. Application of 17β-estradiol (E2) has been shown to inhibit NF-κB, thereby reducing transcription of NF-κB target genes. Despite accumulating evidence showing that estrogens have beneficial effects in pre-clinical AD studies, there are mixed results with hormone replacement therapy in clinical trials. Furthering our understanding of how NF-κB interacts with estrogen and alters the progression of neurodegenerative disorders including AD, should be beneficial and result in the development of novel therapeutics.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“oestrogen regulates transcription factors related to inflammation and oxidative stress, such as nuclear factor kappa-B (NF-κB) and nuclear factor erythroid 2-related factor 2 (Nrf2), to alleviate neuroinflammation and other AD pathologies.469”
From Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances (2025) · cites this paper as [469]
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Role of nrf2 in oxidative stress and toxicity
Ma, Q. (2013) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011112-140320 · Cited by 4,903 · cited 2×
“It controls the expression of several antioxidant response element (ARE)–dependent genes to regulate antioxidant defense within a cell [125].”
BackgroundThe Nuclear Factor NF- B Pathway in Inflammation
Lawrence, T. (2009) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a001651 · Cited by 4,898
Querfurth, H. W., & LaFerla, F. M. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0909142 · Cited by 4,569
NF-κB regulation in the immune system
Li, Q., & Verma, I. M. (2002) · Nature Reviews Immunology · doi:10.1038/nri910 · Cited by 4,007
Hayden, M. S., & Ghosh, S. (2004) · Genes & Development · doi:10.1101/gad.1228704 · Cited by 3,842
A transmembrane intracellular estrogen receptor mediates rapid cell signaling
Revankar, C. M., Cimino, D. F., Sklar, L. A., Arterburn, J. B., & Prossnitz, E. R. (2005) · Science · doi:10.1126/science.1106943 · Cited by 2,302 · cited 1×
“The third ER, GPER1 is a membrane-bound G-protein-coupled receptor without transcriptional activity and mediates E2-regulated rapid non-genomic actions associated with calcium flux, kinase activation, and cross-talk with other ERs [21, 22].”
BackgroundInflammation as a central mechanism in Alzheimer's disease
Kinney, J. W., Bemiller, S. M., Murtishaw, A. S., Leisgang, A. M., Salazar, A. M., & Lamb, B. T. (2018) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1016/j.trci.2018.06.014 · Cited by 2,253 · cited 1×
“However, sustained neuroinflammation can result in neurodegeneration as seen in AD [73].”
BackgroundKobayashi, A., Kang, M.-I., Okawa, H., Ohtsuji, M., Zenke, Y., Chiba, T., Igarashi, K., & Yamamoto, M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.16.7130-7139.2004 · Cited by 2,224
Shumaker, S. A., Legault, C., Rapp, S. R., Thal, L., Wallace, R. B., Ockene, J. K., Hendrix, S. L., Jones III, B. N., Assaf, A. R., Jackson, R. D., et al. (2003) · JAMA · doi:10.1001/jama.289.20.2651 · Cited by 2,178
Research works printed but not linked: 11
- Paterni I et al (2014) Estrogen receptors alpha (ERα) and beta (ERβ): subtype-selective ligands and clinical potential. Steroids 90:13–29 · DOI · Paper page
- Webb P et al (1995) Tamoxifen activation of the estrogen receptor/AP-1 pathway: potential origin for the cell-specific estrogen-like effects of antiestrogens. Mol Endocrinol 9(4):443–456
- Jamshed N et al (2014) Alzheimer disease in post-menopausal women: intervene in the critical window period. J Midlife Health 5(1):38–40
- Honjo H et al (1989) In vivo effects by estrone sulfate on the central nervous system-senile dementia (Alzheimer’s type). J Steroid Biochem 34(1–6):521–525
- Ohkura T et al (1995) Long-term estrogen replacement therapy in female patients with dementia of the Alzheimer type: 7 case reports. Dementia 6(2):99–107
- Naylor JC et al (1801) 2010 Allopregnanolone levels are reduced in temporal cortex in patients with Alzheimer’s disease compared to cognitively intact control subjects. Biochimica et Biophysica Acta (BBA)-Mol Cell Biol Lipids 8:951–959
- Tong KI et al (2006) Two-site substrate recognition model for the Keap1-Nrf2 system: a hinge and latch mechanism. Biol Chem 387(10–11):1311–1320
- Kaplan MH (2013) STAT signaling in inflammation. JAKSTAT 2(1):e24198
- Abdul HM et al (2010) NFATs and Alzheimer’s disease. Mol Cell Pharmacol 2(1):7–14
- Abdi F et al (2016) Hormone therapy for relieving postmenopausal vasomotor symptoms: a systematic review. Archives of Iranian Medicine 19(2): 0–0.
- Gambacciani M, Levancini M (2014) Hormone replacement therapy and the prevention of postmenopausal osteoporosis. Prz Menopauzalny 13(4):213–220
Cited by
Insights and implications of sexual dimorphism in osteoporosis
Zhang, Y., Xie, N., Sun, X., Nice, E. C., Liou, Y., Huang, C., Zhu, H., & Shen, Z. (2024) · Bone Research · doi:10.1038/s41413-023-00306-4 · Cited by 184
“168,169 Second, estradiol promotes apoptosis of bone-resorbing osteoclasts (Fig.”
BackgroundAntiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances
Jiang, Q., Liu, J., Huang, S., Wang, X.-Y., Chen, X., Liu, G.-H., Ye, K., Song, W., Masters, C. L., Wang, J., et al. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02145-7 · Cited by 165
Ali, N., Sohail, R., Jaffer, S. R., Siddique, S., Kaya, B., Atowoju, I., Imran, A., Wright, W., Pamulapati, S., Choudhry, F., et al. (2023) · Cureus · doi:10.7759/cureus.43053 · Cited by 89
“This change is also seen in AD, suggesting estrogen’s role in the pathophysiology of AD [34].”
InfluentialEstrogen-immuno-neuromodulation disorders in menopausal depression
Zhang, Y., Tan, X., & Tang, C. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03152-1 · Cited by 82
“These results suggest that the E2/ ERα/NF-κB signaling pathway regulates cellular or body inflammation levels with diverse outcomes [19, 22, 24, 41, 47–49].”
BackgroundResultEstrogen, menopause, and Alzheimer’s disease: understanding the link to cognitive decline in women
Mervosh, N. L., & Devi, G. (2025) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2025.1634302 · Cited by 67
Metadata
- Authors
- Mishra, P., Davies, D. A., & Albensi, B. C.
- Affiliations
- St. Boniface Hospital (CA)
- York University (CA)
- Nova Southeastern University (US)
- Corresponding author
- Albensi, Benedict C.
- Venue
- Molecular Neurobiology
- Published
- 2022-12-13
- Volume
- 60
- Issue
- 3
- Pages
- 1515-1526
- ISSN
- 0893-7648 (ISSN-L)
- 1559-1182
- OpenAlex
- W4311291025
- Cited by
- 51
- References
- 163
- Citations by year
- 2026: 9 · 2025: 16 · 2024: 17 · 2023: 9
- FWCI
- 1.45
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Molecular Neurobiology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Canadian Institutes of Health Research (PJT-162144)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- Alzheimer's disease, NF-κB, estrogen, estradiol, neuroinflammation, neuroprotection, menopause, hormone replacement therapy, inflammatory cytokines, neurodegeneration, sex differences
- MeSH terms
- Alzheimer Disease, Estradiol, Estrogens, Female, Humans, Male, NF-kappa B
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Interaction Between NF-κB and Estrogen in Alzheimer’s Disease. https://app.cochat.ai/papers/10.1007/s12035-022-03152-3
- The paper
- Mishra, P., Davies, D. A., & Albensi, B. C. (2023). The Interaction Between NF-κB and Estrogen in Alzheimer’s Disease. Molecular Neurobiology. https://doi.org/10.1007/s12035-022-03152-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.